GKOS GLAUKOS Corp

Price (delayed)

$94.56

Market cap

$4.25B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.5

Enterprise value

$4.43B

Sector: Healthcare
Industry: Medical Instruments & Supplies

Highlights

The quick ratio has soared by 64% YoY and by 17% from the previous quarter
The revenue has contracted by 3.4% YoY but it has grown by 3% from the previous quarter
GLAUKOS's EPS has plunged by 183% YoY
The company's gross profit fell by 34% YoY and by 2.9% QoQ

Key stats

What are the main financial stats of GKOS
Market
Shares outstanding
44.96M
Market cap
$4.25B
Enterprise value
$4.43B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.39
Price to sales (P/S)
19.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
20.35
Earnings
Revenue
$217.57M
EBIT
-$138.67M
EBITDA
-$108.07M
Free cash flow
-$43.77M
Per share
EPS
-$1.5
Free cash flow per share
-$0.98
Book value per share
$14.81
Revenue per share
$4.87
TBVPS
$12.63
Balance sheet
Total assets
$994.51M
Total liabilities
$332.95M
Debt
$266.11M
Equity
$661.56M
Working capital
$407.75M
Liquidity
Debt to equity
0.4
Current ratio
9.73
Quick ratio
9.22
Net debt/EBITDA
-1.63
Margins
EBITDA margin
-49.7%
Gross margin
59.5%
Net margin
-33.6%
Operating margin
-65.2%
Efficiency
Return on assets
-8.2%
Return on equity
-11.1%
Return on invested capital
-31%
Return on capital employed
-14.6%
Return on sales
-63.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GKOS stock price

How has the GLAUKOS stock price performed over time
Intraday
2.66%
1 week
1.29%
1 month
10.51%
1 year
54.38%
YTD
25.64%
QTD
25.64%

Financial performance

How have GLAUKOS's revenue and profit performed over time
Revenue
$217.57M
Gross profit
$129.54M
Operating income
-$141.86M
Net income
-$73.12M
Gross margin
59.5%
Net margin
-33.6%
The company's gross profit fell by 34% YoY and by 2.9% QoQ
The gross margin has contracted by 31% YoY and by 6% from the previous quarter
The revenue has contracted by 3.4% YoY but it has grown by 3% from the previous quarter
GLAUKOS's net income has decreased by 3.2% QoQ

Growth

What is GLAUKOS's growth rate over time

Valuation

What is GLAUKOS stock price valuation
P/E
N/A
P/B
6.39
P/S
19.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
20.35
GLAUKOS's EPS has plunged by 183% YoY
The price to book (P/B) is 128% more than the last 4 quarters average of 2.8 but 30% less than the 5-year quarterly average of 9.1
The P/S is 140% higher than the last 4 quarters average of 8.1 and 98% higher than the 5-year quarterly average of 9.8
The revenue has contracted by 3.4% YoY but it has grown by 3% from the previous quarter

Efficiency

How efficient is GLAUKOS business performance
The ROIC is up by 23% since the previous quarter
The return on assets is up by 16% since the previous quarter but it has declined by 11% year-on-year
The ROE has grown by 15% from the previous quarter but it has contracted by 6% YoY
GLAUKOS's ROS has increased by 3.9% from the previous quarter

Dividends

What is GKOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GKOS.

Financial health

How did GLAUKOS financials performed over time
The total assets is 199% greater than the total liabilities
The quick ratio has soared by 64% YoY and by 17% from the previous quarter
GKOS's current ratio has surged by 54% year-on-year and by 18% since the previous quarter
The debt is 60% lower than the equity
The debt to equity has contracted by 4.8% YoY but it has grown by 2.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.